Delivery Order SPE2DB22D1106-SPE2DB24FDSN5
Award Date 12/27/23
Potential Completion Date 12/28/23
Potential Value $8.2K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $10,407.58 firm fixed-price delivery order is for the provision of 4,563,605,046 units of Bupropion HCL XL 150 mg tablets. The contract has an ultimate completion date of February 9, 2024. Amerisourcebergen Drug Corp is an established pharmaceutical distributor that holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,732.67 firm-fixed-price delivery order is for the supply of 4,562,816,824 units of Bupropion HCL XL 150 mg tablets. The award has an ultimate completion date of November 15, 2023. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
- This federal contract award, with ID SPE2DX15D1021|SPE2DX24FHPXD, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $6,901.46 firm-fixed-price delivery order is for 4563501108 - Bupropion HCL XL 300 MG Tablet 500S, with a performance period through February 1, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,539.90 firm fixed-price delivery order is for the supply of 500 count BUPROPION HCL XL 150 MG tablets. The contract has an ultimate completion date of January 18, 2024. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,487.12 firm fixed-price delivery order is for the supply of 4,567,379,185 units of Bupropion HCL XL 300 mg tablets. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,133,134 units of Bupropion HCL XL 150 mg tablets. The contract has a ceiling value of $42,999.30 and a performance period through April 2, 2024. This delivery order contract is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, valued at up to $999,999,999.00...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $51,618.39, is for the delivery of 4,564,448,914 units of Bupropion HCL XL 150 mg tablets. The contract is a firm-fixed-price delivery order with a completion date of May 1, 2024. No set-aside was used for this award. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a critical supplier to various...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, provides for the delivery of 4564247365 - Bupropion HCL XL 150 mg Tablets in 500 count bottles to the Defense Logistics Agency (DLA) Troop Support Medical. The firm fixed price Delivery Order has a ceiling value of $54,382.63 and a period of performance through April 12, 2024. Amerisourcebergen Drug Corp is also the prime contractor on a separate indefinite delivery contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,598.98 firm fixed price delivery order is for the supply of 4,563,970,057 units of the prescription medication Bupropion HCL XL 150 mg tablets. The contract has an ultimate completion date of March 15, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Bupropion HCL XL 150 mg tablets. The contract has a ceiling value of $9,835.33 and is a firm fixed-price delivery order set to expire on January 31, 2024. The contract was awarded on January 30, 2024 and is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FDSN5Delivery Order
This federal contract award, with ID SPE2DB22D1106|SPE2DB24FDSN5, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $8,210.62 firm-fixed-price delivery order is for 4,563,189,541 units of Bupropion HCL XL 150 mg Tablets, to be delivered by December 28, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This order is issued under that IDC. No set-aside designation was used for this award.
Generated 5/13/25, 10:10 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.2k | 12/27/23 |